IFORMULATE
Live / Registered — Registered (as of 31 May 2022)
What this means for you
Registered since 31 May 2022. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90713374
- Registration number
- 6743350
- Mark type
- Stylized text
- Filed
- 15 May 2021
- Published for opposition
- 15 Mar 2022
- Registered
- 31 May 2022
- Attorney of record
- Micah Drayton
Goods and services
- Class 001 — Chemicals: Pre-designed biochemical preparations for use in evaluating biopharmaceutical drug formulations in the nature of liquid formulations of proteins, antibodies, peptides, and other small molecules, and for use in evaluating their respective solubility properties, all the foregoing using Design of Experiments Approach in a multivariate fashion; Pre-designed biochemical preparations for use in evaluating biopharmaceutical drug formulations in the nature of nanoparticle formulations, including investigating parameters related to drug release, particle size, aggregations, and drug integrity, all the foregoing using Design of Experiments Approach in a multivariate fashion; Pre-designed biochemical preparations for use in evaluating biopharmaceutical drug formulations in the nature of vaccine stability formulations, all the foregoing using Design of Experiments Approach in a multivariate fashion; Pre-designed biochemical preparations for use in evaluating biopharmaceutical drug formulations in the nature of antibody conjugates and antibody drug conjugates (ADCs), all the foregoing using Design of Experiments Approach in a multivariate fashion; Pre-designed biochemical preparations for use in evaluating biopharmaceutical drug formulations in the nature of diagnostic reagents and for use in evaluating their stability and compatibility in various formulations with respect to the effect of pH, ionic strength, buffer and stability concentrations, all the foregoing using Design of Experiments Approach in a multivariate fashion
- Class 042 — Scientific and technological services: Scientific research services related to providing an optimum process for identifying stable formulations for biotech drugs such as protein, peptides, and small molecules, using advanced Design of Experiments strategy; Scientific laboratory services related to providing an optimum process for identifying stable formulations for biotech drugs such as protein, peptides, and small molecules, using advanced Design of Experiments strategy
Owner
- HTD Biosystems, Inc., Pleasanton, CA, US
- HTD Biosystems, Inc., Pleasanton, CA, US
- HTD Biosystems, Inc., Pleasanton, CA, US
Prosecution history
- 20 Apr 2023 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 20 Apr 2023 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 20 Apr 2023 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 20 Apr 2023 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 31 May 2022 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 31 May 2022 — REGISTERED-PRINCIPAL REGISTER
- 15 Mar 2022 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 15 Mar 2022 — PUBLISHED FOR OPPOSITION
- 23 Feb 2022 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 10 Feb 2022 — LAW OFFICE PUBLICATION REVIEW COMPLETED
- 08 Feb 2022 — ASSIGNED TO LIE
- 04 Feb 2022 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 31 Jan 2022 — EXAMINER'S AMENDMENT ENTERED
- 31 Jan 2022 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 31 Jan 2022 — EXAMINERS AMENDMENT E-MAILED